Brendan B Springstubb insider trades: Evolent Health (EVH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brendan reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | EVH | ↑ Buy | 10,000 | $3.82 | $38K | Direct | Nov 19, 2025 (1d) |
| Mar 7, 2025 | EVH | ↑ Buy | 15,000 | $9.27 | $139K | Direct | Mar 10, 2025 (3d) |
| Mar 4, 2025 | EVH | ↑ Buy | 5,000 | $8.75 | $44K | Direct | Mar 5, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EVH insiders
Open-market trades in the last 12 months
About Brendan B Springstubb's insider trades
Brendan B Springstubb is a director at Evolent Health (EVH). Since Mar 4, 2025, Brendan has reported 3 open-market purchases worth $221K and no sales on SEC Form 4. In the last 12 months: 1 buy ($38K).
Their filings also include grants and awards (16 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.